A New Approach to Understanding Breast Cancer Treatment Resistance

By Srivani Ravoori, PhD, American Association for Cancer Research This post first appeared on the Cancer Today website. In a study presented Dec. 7 at the San Antonio Breast Cancer Symposium, researchers conducted genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies. They found multiple alterations that were not … Read more

I Have Metastatic Breast Cancer: What Is My Prognosis?

A metastatic breast cancer diagnosis can be a stressful, life-changing event. While metastatic breast cancer it is not curable, it is treatable. Today, with the help of new treatments including biologic targeted therapies and novel drug combinations, many patients with metastatic disease can live well for years.  Metastatic breast cancer means that the cancer has … Read more

FDA Approves New Therapy for Metastatic Breast Cancer

The U.S. Food and Drug Administration has approved a new treatment  for women with advanced (metastatic) breast cancer. The new therapy, palbociclib, will be used to treat postmenopausal women with metastatic estrogen receptor-positive (ER-positive) breast cancer who have not received previous treatment. Palbociclib, which is marketed under the name Ibrance, will be used in combination … Read more